| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.25 | 3e-11 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.24 | 2e-08 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | 0.3 | 1e-07 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.18 | 1e-07 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.19 | 2e-07 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | 0.19 | 4e-07 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.29 | 5e-07 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.17 | 1e-06 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | -0.2 | 1e-06 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.18 | 2e-06 |